The Use of Acrylic Resins for Improved Aqueous Enteric Coating

Under the agreement, AstraZeneca will use Alteogen’s proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Exosomes, polymeric nanoparticles, and DNA nanostructures offer many potential advantages.

In this episode of the Drug Solutions Podcast, industry experts give an overview of the biosimilars market and discuss factors affecting not only their manufacture, but their upstake in the market as well.

European biopharma companies are looking beyond GLP-1s.

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.